← Back to Search

Behavioral Intervention

Eating Condition for Obesity

N/A
Waitlist Available
Led By Kelly Allison, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-post changes between the daytime and delayed eating conditions (8 weeks)
Awards & highlights

Study Summary

This trial is designed to see how the timing of meals affects weight, metabolism, and gene expression in obese people.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-post changes between the daytime and delayed eating conditions (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-post changes between the daytime and delayed eating conditions (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
adiposity
body mass (weight)
energy homeostasis outcomes
Secondary outcome measures
adipose tissue gene expression
Ghrelin
circadian leptin rhythms
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Delayed Eating ConditionExperimental Treatment1 Intervention
Participants will be asked to eat all of their meals and snacks, as provided by the study, between 1200 and 2300.
Group II: Daytime Eating ConditionExperimental Treatment1 Intervention
Participants will be asked to eat all of their meals and snacks, as provided by the study, between 0800 and 1900.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eating Condition
2018
N/A
~50

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,998 Previous Clinical Trials
42,879,351 Total Patients Enrolled
87 Trials studying Obesity
72,437 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,354 Previous Clinical Trials
4,315,297 Total Patients Enrolled
446 Trials studying Obesity
588,908 Patients Enrolled for Obesity
Kelly Allison, PhD4.8422 ReviewsPrincipal Investigator - University of Pennsylvania
Missouri Baptist Medical Center, Saint Luke's Hospital, Mercy Hospital St. Louis
Medical School - University of Pennsylvania, Doctor of Medicine
Mercy Hospital St. Louis, Residency in Obstetrics and Gynecology
1 Previous Clinical Trials
207 Total Patients Enrolled
5Patient Review
Thanks

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this experiment restricted to those over the age of 55?

"This trial grants access to individuals aged between 21 and 50, in accordance with the criteria set forth."

Answered by AI

What is the purpose of this clinical exploration?

"This experiment plans to analyse pre- and post-changes in energy homeostasis over 8 weeks. Other secondary objectives include examining alterations in insulin sensitivity, circadian leptin rhythms, and gene expression profiles."

Answered by AI

Are there any criteria for enrollment in this clinical experimentation?

"Applicants that possess obesity and are between the ages of 21-50 are eligible to join this research. The study is currently recruiting approximately 30 participants."

Answered by AI

Are there any openings in this trial that are available to participants?

"The information on clinicaltrials.gov denotes that this research is not presently enrolling patients; it was initially posted in February 2018 and last modified in November 2022. Nevertheless, there are 956 other trials currently recruiting participants."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
~4 spots leftby Apr 2025